Esketamine
Showing 26 - 50 of 192
Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine, Dexmedetomidine, Sufentanil)
Active, not recruiting
- Scoliosis Correction
- +4 more
- Esketamine
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Feb 7, 2023
Gynecological; Surgery (Previous), Affecting Fetus or Newborn, Due to Obstructed Labor, Analgesia Trial in Dazhou (2 mg morphine
Completed
- Gynecological; Surgery (Previous), Affecting Fetus or Newborn, Due to Obstructed Labor
- Analgesia
- 2 mg morphine sulfate
- +3 more
-
Dazhou, Sichuan, ChinaQijun Ran
Oct 13, 2022
Total Hip Arthroplasty Trial in Changzhou (esketamine sub-anesthetic,, esketamine sub-anesthetic)
Completed
- Total Hip Arthroplasty
- esketamine sub-anesthetic,
- esketamine sub-anesthetic
-
Changzhou, Jiangsu, ChinaChangzhouTCMH
Oct 26, 2022
Intensive Care Unit, Mechanical Ventilation, Dexmedetomidine Trial (Dexmedetomidine-esketamine, Propofol-remifentanil)
Not yet recruiting
- Intensive Care Unit
- +4 more
- (no location specified)
Feb 6, 2023
Depression Trial in Shenyang (Esketamine, Saline Solution)
Recruiting
- Depression
- Esketamine
- Saline Solution
-
Shenyang, Liaoning, Chinathe First Hospital of China Medical University
Jan 15, 2023
MDD Trial (Ketamine, Esketamine)
Recruiting
- Major Depressive Disorder
- Ketamine
- Esketamine
-
Boston, MassachusettsMassachusetts General Hospital
Jan 20, 2023
Breast Cancer, Perioperative Period, Dexmedetomidine Trial (Dexmedetomidine, Esketamine, Normal saline)
Not yet recruiting
- Breast Cancer
- +4 more
- Dexmedetomidine
- +2 more
- (no location specified)
Feb 7, 2023
Usage ofAnalgesic Dose of Esketamine for Treatment of Moderate
Recruiting
- Pain, Acute
- Esketamine perfusion
-
Nice, Alpes Maritimes, FranceCentre Hospitalier Universitaire de Nice
Dec 23, 2022
Analgesia, Burns Trial (Esketamine 0.1mg/kg intravenous injection, Normal saline)
Not yet recruiting
- Analgesia
- Burns
- Esketamine 0.1mg/kg intravenous injection
- Normal saline
- (no location specified)
Oct 29, 2022
Depressive Episode Trial in New Haven (Pre and Post Treatment Presentations)
Not yet recruiting
- Depressive Episode
- Pre and Post Treatment Presentations
-
New Haven, ConnecticutYale Psychiatry Hospital Interventional Psychiatry Services (IPS
Jun 6, 2023
Emergence Agitation Trial in Shanghai (Esketamine, Sevoflurane)
Recruiting
- Emergence Agitation
- Esketamine
- Sevoflurane
-
Shanghai, Shanghai, ChinaAnesthesiology Department of Affiliated Eye and ENT Hospital, Fu
Dec 3, 2022
Esketamine, Thoracoscopic Surgery Trial in Chongqing (Esketamine)
Recruiting
- Esketamine
- Thoracoscopic Surgery
- Esketamine
-
Chongqing, Chongqing, China
- +1 more
Aug 15, 2022
Patients Undergoing General Anesthesia Laparoscopic Uterine Surgery Trial in Yangzhou (esketamine)
Recruiting
- Patients Undergoing General Anesthesia Laparoscopic Uterine Surgery
- esketamine
-
Yangzhou, Jiangsu, Chinathe Affiliated Hospital of Yangzhou University
Feb 6, 2023
Depression Trial in Yangzhou (Esketamine, normal saline)
Completed
- Depression
- Esketamine
- normal saline
-
Yangzhou, Jiangsu, ChinaAffiliated hospital of yangzhou university
Jul 27, 2022
Anesthesia, Abortion Early Trial in Wuhan (Remimazolam, Propofol, Esketamine)
Completed
- Anesthesia
- Abortion Early
- Remimazolam
- +2 more
-
Wuhan, Hubei, ChinaMaternal and Child Health Hospital of Hubei Province
Nov 22, 2022
Depression Trial in Pittsburgh (Cognitive Training, Sham Training)
Not yet recruiting
- Depression
- Cognitive Training
- Sham Training
-
Pittsburgh, PennsylvaniaWestern Psychiatric Institute and Clinic
Feb 13, 2023
Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Chongqing (Esketamine, Sufentanil)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- Esketamine
- Sufentanil
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital, Chongqing Medical University
Jan 2, 2023
Critically Ill Patients Trial (Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato], midazolam, fentanyl)
Not yet recruiting
- Critically Ill Patients
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- midazolam, fentanyl
- (no location specified)
Jul 17, 2022
Treatment Resistant Depression, MDD Trial in Innsbruck (Esketamine nasal spray, Electroconvulsive therapy)
Withdrawn
- Treatment Resistant Depression
- Major Depressive Disorder
- Esketamine nasal spray
- Electroconvulsive therapy
-
Innsbruck, Tyrol, AustriaMedical University Innsbruck
Aug 2, 2022
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, KetanestĀ®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Treatment Resistant MDD Trial (Psychotherapy, Treatment as Usual, Intranasal Ketamine (esketamine))
Recruiting
- Treatment Resistant Major Depressive Disorder
- Psychotherapy
- +2 more
-
Edmonton, Alberta, CanadaCity Center Pharmacy and Medical Clinic
Nov 9, 2022
Prenatal Depression, Ketamine, Postpartum Depression Trial in China (Esketamine, Placebo)
Active, not recruiting
- Prenatal Depression
- +2 more
- Esketamine
- Placebo
-
Changsha, Hunan, China
- +3 more
Jan 24, 2023
Dexmedetomidine, Esketamine, Postoperative Pain and Recovery Quality Trial in Anqing (Dexmedetomidine infusion,
Recruiting
- Dexmedetomidine, Esketamine, Postoperative Pain and Recovery Quality
- Dexmedetomidine infusion
- +2 more
-
Anqing, Anhui, ChinaDepartment of Anqing Hospital Anesthesiology
May 3, 2022